KR860003256A - 아데노신의 n^6-치환된 데옥시리보스 유사체의 제조방법 - Google Patents
아데노신의 n^6-치환된 데옥시리보스 유사체의 제조방법 Download PDFInfo
- Publication number
- KR860003256A KR860003256A KR1019850007937A KR850007937A KR860003256A KR 860003256 A KR860003256 A KR 860003256A KR 1019850007937 A KR1019850007937 A KR 1019850007937A KR 850007937 A KR850007937 A KR 850007937A KR 860003256 A KR860003256 A KR 860003256A
- Authority
- KR
- South Korea
- Prior art keywords
- adenosine
- preparing
- substituted deoxyribose
- deoxyribose analogs
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 다음 일반식 (2)의 N-6-치환푸린을 상승된 온도에서, 약 1-12시간동안 다음 일반식 (3)의 화합물과 반응시켜 다음 일반식(1)의 화합물을 제조하는 방법.
-
-
- ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66523384A | 1984-10-26 | 1984-10-26 | |
US66521784A | 1984-10-26 | 1984-10-26 | |
US66523284A | 1984-10-26 | 1984-10-26 | |
US665,232 | 1984-10-26 | ||
US665,217 | 1984-10-26 | ||
US772,315 | 1985-06-09 | ||
US77231585A | 1985-09-06 | 1985-09-06 | |
US665,233 | 1991-03-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860003256A true KR860003256A (ko) | 1986-05-21 |
KR910002226B1 KR910002226B1 (ko) | 1991-04-08 |
Family
ID=27505316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850007937A KR910002226B1 (ko) | 1984-10-26 | 1985-10-26 | 아데노이신의 n6-치환된 데옥시리보스 동족체 및 그 제조방법 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0181129B1 (ko) |
KR (1) | KR910002226B1 (ko) |
CN (1) | CN1013448B (ko) |
AU (1) | AU575438B2 (ko) |
CA (1) | CA1260931A (ko) |
DE (1) | DE3568582D1 (ko) |
DK (1) | DK488485A (ko) |
ES (1) | ES8701774A1 (ko) |
FI (1) | FI81587C (ko) |
GR (1) | GR852583B (ko) |
NO (1) | NO165495C (ko) |
NZ (1) | NZ213971A (ko) |
PT (1) | PT81373B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206497B1 (en) * | 1985-05-15 | 1994-07-20 | The Wellcome Foundation Limited | Therapeutic nucleosides and their preparation |
WO1988003147A1 (en) * | 1986-10-31 | 1988-05-05 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
GB2226027B (en) * | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
JPH0725785B2 (ja) * | 1989-01-11 | 1995-03-22 | 日本臓器製薬株式会社 | アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物 |
ZA902280B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor agents |
US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
ATE147074T1 (de) * | 1990-09-25 | 1997-01-15 | Rhone Poulenc Rorer Int | Verbindungen welche antihypertensive und antiischemische eigenschaften besitzen |
US5705491A (en) * | 1992-10-27 | 1998-01-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Adenosine deaminase inhibitor |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
ES2159760T3 (es) * | 1995-11-14 | 2001-10-16 | Pharmacia & Upjohn Spa | Derivados de aril purina y piridopirimidina y de heteroaril purina y piridopirimidina. |
TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
SK19542000A3 (sk) | 1998-06-23 | 2001-09-11 | Glaxo Group Limited | 2-(purin-9-yl)-tetrahydrofurn-3,4-diolov derivty, spsob ich vroby, farmaceutick prostriedok s ich obsahom, ich pouitie a medziprodukty |
JP3619017B2 (ja) | 1998-06-24 | 2005-02-09 | 日本臓器製薬株式会社 | 新規アラビノシルアデニン誘導体 |
US7157440B2 (en) | 2001-07-13 | 2007-01-02 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
US7713946B2 (en) | 2002-07-11 | 2010-05-11 | Cv Therapeutics, Inc. | Partial and full agonists A1 adenosine receptors |
US6946449B2 (en) | 2001-07-13 | 2005-09-20 | Cv Therapeutics, Inc. | Partial and full agonists of A1 adenosine receptors |
EP1375508A1 (en) * | 2002-06-27 | 2004-01-02 | Aventis Pharma Deutschland GmbH | N6-substituted adenosine analogues and their use as pharmaceutical agents |
US7265111B2 (en) | 2002-06-27 | 2007-09-04 | Sanofi-Aventis Deutschland Gmbh | Adenosine analogues and their use as pharmaceutical agents |
CA2515068A1 (en) | 2003-02-03 | 2004-08-19 | Cv Therapeutics Inc. | Partial and full agonists of a1 adenosine receptors |
AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1545645A1 (de) * | 1965-12-06 | 1969-08-21 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von disubstituierten Adenosin-Derivaten |
DE1670077C3 (de) * | 1966-05-07 | 1975-04-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Adenosin-Derivate und Verfahren zu ihrer Herstellung |
SE361760B (ko) * | 1972-04-05 | 1973-11-12 | Haldex Ab | |
DE2230160A1 (de) * | 1972-06-21 | 1974-01-31 | Merck Patent Gmbh | Adenosinderivat |
US4373097A (en) * | 1981-04-27 | 1983-02-08 | Bioresearch S.R.L. | Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity |
EP0305643B1 (en) * | 1984-04-18 | 1994-01-05 | Whitby Research Incorporated | N-6 thienyl substituted adenosine derivatives as cardiac vasodilators |
US5310731A (en) * | 1984-06-28 | 1994-05-10 | Whitby Research, Inc. | N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents |
AU577743B2 (en) * | 1984-10-26 | 1988-09-29 | Warner-Lambert Company | N6-benzopyrano and benzothiopyrano adenosines |
-
1985
- 1985-10-21 AU AU48888/85A patent/AU575438B2/en not_active Ceased
- 1985-10-23 FI FI854153A patent/FI81587C/fi not_active IP Right Cessation
- 1985-10-24 DK DK488485A patent/DK488485A/da not_active Application Discontinuation
- 1985-10-25 GR GR852583A patent/GR852583B/el unknown
- 1985-10-25 EP EP85307717A patent/EP0181129B1/en not_active Expired
- 1985-10-25 NZ NZ213971A patent/NZ213971A/en unknown
- 1985-10-25 NO NO854278A patent/NO165495C/no unknown
- 1985-10-25 ES ES548238A patent/ES8701774A1/es not_active Expired
- 1985-10-25 CA CA000493849A patent/CA1260931A/en not_active Expired
- 1985-10-25 DE DE8585307717T patent/DE3568582D1/de not_active Expired
- 1985-10-25 PT PT81373A patent/PT81373B/pt not_active IP Right Cessation
- 1985-10-26 CN CN85108658A patent/CN1013448B/zh not_active Expired
- 1985-10-26 KR KR1019850007937A patent/KR910002226B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DK488485D0 (da) | 1985-10-24 |
ES8701774A1 (es) | 1986-12-01 |
CA1260931A (en) | 1989-09-26 |
KR910002226B1 (ko) | 1991-04-08 |
FI854153A0 (fi) | 1985-10-23 |
EP0181129A2 (en) | 1986-05-14 |
AU575438B2 (en) | 1988-07-28 |
CN85108658A (zh) | 1986-07-16 |
DK488485A (da) | 1986-04-27 |
NO854278L (no) | 1986-04-28 |
NO165495B (no) | 1990-11-12 |
FI854153L (fi) | 1986-04-27 |
NO165495C (no) | 1991-02-20 |
CN1013448B (zh) | 1991-08-07 |
EP0181129A3 (en) | 1987-05-13 |
PT81373B (pt) | 1987-11-11 |
GR852583B (ko) | 1986-02-26 |
AU4888885A (en) | 1986-05-08 |
DE3568582D1 (en) | 1989-04-13 |
ES548238A0 (es) | 1986-12-01 |
NZ213971A (en) | 1988-03-30 |
FI81587B (fi) | 1990-07-31 |
FI81587C (fi) | 1990-11-12 |
EP0181129B1 (en) | 1989-03-08 |
PT81373A (en) | 1985-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR860003256A (ko) | 아데노신의 n^6-치환된 데옥시리보스 유사체의 제조방법 | |
KR840005098A (ko) | 피리딜(옥시/티오) 페녹시 화합물의 제조방법 | |
KR840001145A (ko) | 피리다진의 아미노 화합물의 제조방법 | |
KR840005101A (ko) | 2-퀴놀린유도체의 제조방법 | |
KR910007945A (ko) | 알킬 메틸-3-카브알콕시에틸포스피네이트의 제조방법 | |
KR830009077A (ko) | 푸란 유도체의 제조방법 | |
KR870010065A (ko) | 인산 에스테르 및 그의 제조방법 | |
KR860002473A (ko) | 4-메틸-5-티오포름아미디노메틸이미다졸 디하이드로클로라이드의 제조방법 | |
KR840002367A (ko) | 3-메틸-3-(4-아세틸아미노펜옥시)-2,4-디옥사벤조-사이클로헥사논-1-의 제조방법 | |
KR830002773A (ko) | 3-티에닐 말론산의 제조방법 | |
KR830004269A (ko) | Δ²-1,2,4-트리아졸린-5-온류의 제법 | |
KR870007914A (ko) | 치환된 피리미딘 유도체의 제조방법 | |
KR930700440A (ko) | 3,4,6-트리플루오로프탈산의 제조방법 | |
KR830002797A (ko) | 알킬-케토헥소 피라노사이드 유도체의 제조방법 | |
KR850005413A (ko) | 아미노니트로피리딘의 제조방법 | |
KR840002848A (ko) | 유기인산염의 제조방법 | |
KR830002798A (ko) | 알킬-케토헥소 피라노사이드 유도체의 제조방법 | |
KR830001184A (ko) | 페닐 알카노일산 유도체의 제조방법 | |
KR890009949A (ko) | 디알킬디티오인산아연염의 제조방법 | |
KR870002061A (ko) | 페닐렌기를 가지는 스페르구알린계 화합물의 제조 방법 | |
KR880011174A (ko) | 세펨 유도체의 제조방법 | |
KR830002817A (ko) | 불소화 비닐 에테르 화합물의 제조방법 | |
KR840009305A (ko) | 환으로 치환된 피라지노 이소퀴놀린 유도체의 제조방법 | |
KR860008996A (ko) | 구아니디노 티아졸 화합물의 제조방법 | |
KR920002599A (ko) | 플루오르화 퓨린핵산의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
NORF | Unpaid initial registration fee |